$10.45
-0.36-3.33%
At Close: -
$10.97
0.524.98%
After Hours: 5:54 PM EDT
15 minutes delayed
IGM Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of IGM Biosciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $-0.79 | $-0.04 | -1875.0 % |
Mar 2024 | 2024-05-08 | $-0.83 | $-0.83 | 0.00 % |
Dec 2023 | 2024-03-07 | $-1.01 | $-1.03 | 1.94 % |
Sep 2023 | 2023-11-13 | $-1.04 | $-1.22 | 14.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $1.25M | $54.31M | -97.7 % |
Mar 2024 | 2024-05-08 | $497.00K | $760.00K | -34.6 % |
Dec 2023 | 2024-03-07 | $651.00K | $700.00K | -7.00 % |
Sep 2023 | 2023-11-13 | $509.00K | $780.00K | -34.7 % |
IGM Biosciences (IGMS) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
The Actual EPS was $-0.79, which missed the estimate of $-0.04.
The Actual Revenue was $1.3M, which missed the estimate of $54.3M.
Browse earnings estimates, EPS, and revenue on all stocks.